Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
15 03 2022
15 03 2022
Historique:
received:
02
05
2021
accepted:
18
02
2022
entrez:
16
3
2022
pubmed:
17
3
2022
medline:
6
4
2022
Statut:
epublish
Résumé
In prostate cancer, emerging data highlight the role of DNA damage repair genes (DDRGs) in aggressive forms of the disease. However, DDRG mutations in African American men are not yet fully defined. Here, we profile germline mutations in all known DDRGs (N = 276) using whole genome sequences from blood DNA of a matched cohort of patients with primary prostate cancer comprising of 300 African American and 300 European Ancestry prostate cancer patients, to determine whether the mutation status can enhance patient stratification for specific targeted therapies. Here, we show that only 13 of the 46 DDRGs identified with pathogenic/likely pathogenic mutations are present in both African American and European ancestry patients. Importantly, RAD family genes (RAD51, RAD54L, RAD54B), which are potentially targetable, as well as PMS2 and BRCA1, are among the most frequently mutated DDRGs in African American, but not in European Ancestry patients.
Identifiants
pubmed: 35292633
doi: 10.1038/s41467-022-28945-x
pii: 10.1038/s41467-022-28945-x
pmc: PMC8924169
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1361Informations de copyright
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Références
Int J Cancer. 2021 Feb 1;148(3):673-681
pubmed: 33006389
Am J Hum Genet. 2017 Mar 2;100(3):406-413
pubmed: 28190455
Int J Oncol. 2018 Sep;53(3):923-936
pubmed: 30015870
Hum Mol Genet. 2016 Jan 15;25(2):371-81
pubmed: 26604137
Expert Opin Ther Targets. 2014 Apr;18(4):427-58
pubmed: 24491188
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Prostate Cancer Prostatic Dis. 2021 Sep 2;:
pubmed: 34475523
Eur Urol. 2020 Oct;78(4):486-488
pubmed: 32636098
N Engl J Med. 2015 Oct 29;373(18):1697-708
pubmed: 26510020
Eur Urol. 2018 Aug;74(2):218-225
pubmed: 29439820
JAMA Oncol. 2019 Apr 1;5(4):523-528
pubmed: 30730552
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Nucleic Acids Res. 2014 Dec 16;42(22):13534-44
pubmed: 25416802
Urol Oncol. 2009 Sep-Oct;27(5):562-9
pubmed: 19720304
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
JCO Oncol Pract. 2020 Dec;16(12):811-819
pubmed: 32986533
BMC Bioinformatics. 2015 Apr 19;16:123
pubmed: 25928477
PLoS One. 2015 Oct 15;10(10):e0139846
pubmed: 26468652
J Clin Oncol. 2019 Feb 20;37(6):490-503
pubmed: 30625039
Nucleic Acids Res. 2017 Jan 4;45(D1):D840-D845
pubmed: 27899611
Nat Rev Urol. 2018 Feb;15(2):125-131
pubmed: 28872154
Prostate. 2018 Apr;78(5):321-326
pubmed: 29356034
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Int J Mol Sci. 2018 Apr 22;19(4):
pubmed: 29690565
Prostate Cancer Prostatic Dis. 2019 Sep;22(3):406-410
pubmed: 30542053
JCO Precis Oncol. 2020;4:32-43
pubmed: 32832836
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Nat Rev Urol. 2012 Feb 14;9(3):131-7
pubmed: 22331093
Eur Urol Oncol. 2022 Feb;5(1):18-29
pubmed: 34446369
Cell Cycle. 2019 Aug;18(15):1770-1783
pubmed: 31238782
Can J Urol. 2019 Oct;26(5 Suppl 2):1-4
pubmed: 31629412
Cell Rep. 2018 Apr 03;23(1):239-254.e6
pubmed: 29617664
Oncologist. 2021 Jan;26(1):e115-e129
pubmed: 32790034
Cell. 2018 Apr 5;173(2):355-370.e14
pubmed: 29625052
Genes (Basel). 2021 Jun 16;12(6):
pubmed: 34208492
Cancer Invest. 2019;37(2):113-126
pubmed: 30836777
Genes Chromosomes Cancer. 2017 Jul;56(7):513-523
pubmed: 28295846
Bioinformatics. 2015 Mar 1;31(5):761-3
pubmed: 25338716
J Clin Oncol. 2019 Jun 10;37(17):1455-1459
pubmed: 30978156
Oncotarget. 2020 Jan 28;11(4):440-442
pubmed: 32064047
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Prostate. 2021 May;81(7):433-439
pubmed: 33792945
Nat Methods. 2018 Aug;15(8):591-594
pubmed: 30013048
Cancer. 2017 Sep 15;123(18):3532-3539
pubmed: 28608931
Nat Commun. 2020 May 26;11(1):2639
pubmed: 32457312
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890
Breast Cancer Res. 2019 Sep 6;21(1):104
pubmed: 31492187
Eur Urol Oncol. 2021 Feb;4(1):1-9
pubmed: 33390340
J Med Chem. 2020 Mar 12;63(5):2588-2619
pubmed: 32037829
Eur Urol. 2017 Mar;71(3):417-425
pubmed: 27590317
N Engl J Med. 2016 Aug 4;375(5):443-53
pubmed: 27433846
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669